Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis ; volume:9 ; number:1 ; day:29 ; month:1 ; year:2019 ; pages:1-17 ; date:12.2019
Scientific reports ; 9, Heft 1 (29.1.2019), 1-17, 12.2019
- Urheber
-
Hooijmans, Carlijn R.
Hlavica, Martin
Schuler, Florian A. F.
Good, Nicolas
Good, Andrin
Baumgartner, Lisa
Galeno, Gianluca
Schneider, Marc P.
Jung, Tarzis
Vries, Rob de
Ineichen, Benjamin V.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35734-4
- URN
-
urn:nbn:de:101:1-2019022518481504968762
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hooijmans, Carlijn R.
- Hlavica, Martin
- Schuler, Florian A. F.
- Good, Nicolas
- Good, Andrin
- Baumgartner, Lisa
- Galeno, Gianluca
- Schneider, Marc P.
- Jung, Tarzis
- Vries, Rob de
- Ineichen, Benjamin V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Promoting remyelination in multiple sclerosis
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Glia during de-and remyelination
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
Promoting remyelination in multiple sclerosis
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Glia during de-and remyelination
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination
Promoting remyelination in multiple sclerosis
In vivo analysis of demyelination and remyelination in an animal model of multiple sclerosis
Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair
Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
Impact of multiple sclerosis treatments on the rate of cerebral remyelination assessed by advanced neuroimaging
Glia during de-and remyelination
Region-specific characterization of the cuprizone model for Multiple Sclerosis and impairment of remyelination by corticosteroids
Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis